Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTX-1472 in Social Anxiety Disorder
NCT07323784Phase 2Recruiting
- Sponsor
- Newleos Therapeutics
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO6953958 in Social Anxiety Disorder (SAD), sponsored by Newleos Therapeutics. Started Dec 2025; status: recruiting.
02
Drugs
RO6953958
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT07323784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323784.